
Journal of the Less-Common Metals p. 243 - 254 (1991)
Update date:2022-08-31
Topics:
Mobin, M.
Malik, A. U.
The high-temperature (900-1200 K) interaction of transition-metal carbides namely Cr7C3, Fe3C, TiC, ZrC, NbC, TaC, MoC, WC, VC and HfC with Na2SO4 has been studied in a stream of pure and dried oxygen gas. Thermogravimetric studies were carried out by measuring the weight change as a function of time and mole fraction of Na2SO4 in the reaction mixture. The presence of different constituents in the reaction products were identified by X-ray diffraction analysis and the morphologies of the reaction products were discussed on the basis of metallography, scanning electron microscopy (SEM) and energy dispersive X-ray analysis (EDAX). The quantitative determination of soluble metal species in the aqueous solutions of Na2SO4-transition-metal carbide products was carried out by atomic absorption spectroscopy. At high temperatures, transition-metal carbides interact with Na2SO4, forming metal oxides. The resulting metal oxide interacts with Na2SO4 forming a soluble sodium metal oxide or a metal sulphide depending upon the local condition prevailing during the reaction.
Chemieliva Pharmaceutical Co., Ltd.
website:http://www.chemieliva.com
Contact:+86-23-67770219
Address:99 Longhua Road, Yubei District, 401147, Chongqing, China Email: sales@chemieliva.com Tel:0086-23-67770219 Fax: 0086-23-67770220 Attn: Andy Huang
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
website:http://www.mingchem.com/en/index
Contact:0519-85170101-802
Address:Fifth Floor,B of Beihua Buliding,520 Road of Science and Education City,Changwu middle road NO.801,Wujin District,Changzhou,Jiangsu province
Longhui qunfeng Chemical Co., Ltd
Contact:86-731-82173407
Address:South-east Industrial Park, Longhui County, Hunan Province, China
Suzhou Chiral Pharmaceuticals Co., Ltd.
Contact:86-0512-63197058
Address:Building A, No. 2358, Chang'an Road, Wujiang Science Park
Doi:10.1002/anie.201409853
(2015)Doi:10.1021/acs.molpharmaceut.7b00569
(2017)Doi:10.1021/ja00209a036
(1988)Doi:10.1039/b001823f
(2000)Doi:10.1063/1.430588
(1975)Doi:10.1016/0006-3002(59)90665-1
(1954)